3Machata AM,Gonano C,Holzer A,et al.Awake nasotracheal fiberoptic intubation:patient comfort,intubating conditions,and hemodynamic stability during conscious sedation with remifentanil.Anesth Analg,2003,97:904-908.
4Milne SE,Kenny GN,Schraag S.Propofol sparing effect of remifentanil using closed-loop anaesthesia.Br J Anaesth,2003,90:623-629.
5Hall AP,Thompson JP,Leslie NA,et al.Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation.Br J Anaesth,2000,84:100-102.
6Egan TD,Kern SE,Muir KT,et al.Remifentanil by bolus injection:a safety,pharmacokinetic,pharmacodynamic,and age effect investigation in human volunteers.Br J Anaesth,2004,92:335-343.
7Glass PS,Gan TJ,Howell S.A review of the pharmacokinetics and pharmacodynamics of remifentanil.Anesth Analg,1999,89 (Suppl 4):7-14.
8Nieuwenhuijs DJ,Olofsen E,Romberg RR,et al.Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index.Anesthesiology,2003,98:312-322.
9Mertens MJ,Olofsen E,Engbers FH,et al.Propofol reduces perioperative remifentanil requirements in a synergistic manner:response surface modeling of perioperative remifentanil-propofol interactions.Anesthesiology,2003,99:347-359.
